+关注
虎皮猫
暂无个人介绍
IP属地:浙江
9
关注
1
粉丝
1
主题
0
勋章
主贴
热门
虎皮猫
2020-08-14
$英特尔(INTC)$
感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会
虎皮猫
2020-08-15
$TFF Pharmaceuticals(TFFP)$
Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。
虎皮猫
2020-09-04
快
抱歉,原内容已删除
虎皮猫
2020-09-10
听听就好了
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"77318222255148","uuid":"77318222255148","gmtCreate":1455429309257,"gmtModify":1460385371745,"name":"虎皮猫","pinyin":"hpmhupimao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","hat":"https://static.tigerbbs.com/e6295840391b9cdc17115677ba51429c","hatId":"tiger_head_frame","hatName":"小虎头像框","vip":1,"status":2,"fanSize":1,"headSize":9,"tweetSize":4,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":15,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":4,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":976606803,"gmtCreate":1599674612502,"gmtModify":1703819349712,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"听听就好了","listText":"听听就好了","text":"听听就好了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/976606803","repostId":"2066247378","repostType":2,"repost":{"id":"2066247378","pubTimestamp":1599659084,"share":"https://www.laohu8.com/m/news/2066247378?lang=&edition=full","pubTime":"2020-09-09 21:44","market":"us","language":"en","title":"Benzinga's Top Upgrades, Downgrades For September 9, 2020","url":"https://stock-news.laohu8.com/highlight/detail?id=2066247378","media":"Benzinga","summary":"UpgradesFor Duke Energy Corp (NYSE: DUK), B of A Securities upgraded the previous rating of Neutral ","content":"<html><body><div><p type=\"text\">Upgrades</p><ul><li>For <strong>Duke Energy Corp</strong> (NYSE: DUK), B of A Securities upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Duke Energy showed an EPS of $1.08, compared to $1.12 from the year-ago quarter. The stock has a 52-week-high of $103.79 and a 52-week-low of $62.13. At the end of the last trading period, Duke Energy closed at $80.67.</li><li>BMO Capital upgraded the previous rating for <strong>Sherwin-Williams Co</strong> (NYSE: SHW) from Market Perform to Outperform. In the second quarter, Sherwin-Williams showed an EPS of $7.10, compared to $6.57 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of $699.81 and a 52-week-low of $325.43. Moreover, at the end of the last trading period, the closing price was at $669.41.</li><li>According to Wolfe Research, the prior rating for <strong>SmileDirectClub Inc</strong> (NASDAQ: SDC) was changed from Underperform to Peer Perform. Interestingly, in the second quarter, SmileDirectClub's EPS was $0.13. The current stock performance of SmileDirectClub shows a 52-week-high of $21.10 and a 52-week-low of $3.64. Moreover, at the end of the last trading period, the closing price was at $10.57.</li><li>For <strong><a href=\"https://laohu8.com/S/THO\">Thor Industries Inc</a></strong> (NYSE: THO), BMO Capital upgraded the previous rating of Market Perform to the current rating Outperform. For the third quarter, Thor Industries had an EPS of $0.43, compared to year-ago quarter EPS of $1.65. The current stock performance of Thor Industries shows a 52-week-high of $121.33 and a 52-week-low of $32.30. Moreover, at the end of the last trading period, the closing price was at $92.41.</li><li>For <strong><a href=\"https://laohu8.com/S/ARMK\">Aramark</a></strong> (NYSE: ARMK), Goldman Sachs upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, Aramark showed an EPS of $0.69, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $47.22 and a 52-week-low of $9.65. At the end of the last trading period, Aramark closed at $27.94.</li><li>For <strong>Invitation Homes Inc</strong> (NYSE: INVH), Goldman Sachs upgraded the previous rating of Sell to the current rating Buy. Invitation Homes earned $0.32 in the second quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Invitation Homes shows a 52-week-high of $32.70 and a 52-week-low of $15.64. Moreover, at the end of the last trading period, the closing price was at $28.19.</li><li>Deutsche Bank upgraded the previous rating for <strong>Vivint Smart Home Inc</strong> (NYSE: VVNT) from Hold to Buy. Vivint Smart Home earned $0.49 in the second quarter. The stock has a 52-week-high of $32.00 and a 52-week-low of $8.51. At the end of the last trading period, Vivint Smart Home closed at $15.58.</li><li>MKM Partners upgraded the previous rating for <strong>Continental Resources Inc</strong> (NYSE: CLR) from Neutral to Buy. Continental Resources earned $0.71 in the second quarter, compared to $0.59 in the year-ago quarter. The current stock performance of Continental Resources shows a 52-week-high of $40.25 and a 52-week-low of $6.90. Moreover, at the end of the last trading period, the closing price was at $14.13.</li></ul><div><div><div><div></div></div></div></div><p type=\"text\">Downgrades</p><ul><li>According to Cowen & Co., the prior rating for <strong>Gogo Inc</strong> (NASDAQ: GOGO) was changed from Outperform to Market Perform. For the second quarter, Gogo had an EPS of $1.04, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $10.68 and a 52-week-low of $1.33. Gogo closed at $9.06 at the end of the last trading period.</li><li>For <strong>Apartment Investment & Management Co</strong> (NYSE: AIV), Goldman Sachs downgraded the previous rating of Buy to the current rating Neutral. For the second quarter, Apartment Inv & Mgmt had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The current stock performance of Apartment Inv & Mgmt shows a 52-week-high of $55.68 and a 52-week-low of $24.53. Moreover, at the end of the last trading period, the closing price was at $36.79.</li><li>For <strong>Essex Property Trust Inc</strong> (NYSE: ESS), Piper Sandler downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Essex Property Trust had an EPS of $3.16, compared to year-ago quarter EPS of $3.33. At the moment, the stock has a 52-week-high of $334.17 and a 52-week-low of $175.81. Essex Property Trust closed at $221.74 at the end of the last trading period.</li></ul><p type=\"text\">Initiations</p><ul><li><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> initiated coverage on <strong><a href=\"https://laohu8.com/S/VCYT\">Veracyte Inc</a></strong> (NASDAQ: VCYT) with an Underweight rating. The price target for Veracyte is set to $35.00. Veracyte earned $0.22 in the second quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Veracyte shows a 52-week-high of $36.42 and a 52-week-low of $13.90. Moreover, at the end of the last trading period, the closing price was at $30.70.</li><li>Morgan Stanley initiated coverage on <strong><a href=\"https://laohu8.com/S/SPR\">Spirit AeroSystems Holdings Inc</a></strong> (NYSE: SPR) with an Underweight rating. The price target for Spirit AeroSystems Hldgs is set to $18.00. Spirit AeroSystems Hldgs earned $2.28 in the second quarter, compared to $1.71 in the year-ago quarter. The stock has a 52-week-high of $92.81 and a 52-week-low of $13.69. At the end of the last trading period, Spirit AeroSystems Hldgs closed at $20.23.</li><li>Morgan Stanley initiated coverage on <strong>Pacific Biosciences of California Inc</strong> (NASDAQ: PACB) with a Equal-Weight rating. The price target for Pacific Biosciences is set to $7.00. In the second quarter, Pacific Biosciences showed an EPS of $0.15, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.25 and a 52-week-low of $2.20. Pacific Biosciences closed at $6.51 at the end of the last trading period.</li><li>With a current rating of Equal-Weight, Morgan Stanley initiated coverage on <strong>NanoString Technologies Inc</strong> (NASDAQ: NSTG). The price target seems to have been set at $43.00 for NanoString Technologies. NanoString Technologies earned $0.72 in the second quarter, compared to $0.57 in the year-ago quarter. The current stock performance of NanoString Technologies shows a 52-week-high of $42.32 and a 52-week-low of $13.85. Moreover, at the end of the last trading period, the closing price was at $37.95.</li><li>With a current rating of Outperform, Evercore ISI Group initiated coverage on <strong>DraftKings Inc</strong> (NASDAQ: DKNG). The price target seems to have been set at $60.00 for DraftKings. In the second quarter, DraftKings showed an EPS of $0.55, compared to $0.15 from the year-ago quarter. The current stock performance of DraftKings shows a 52-week-high of $44.79 and a 52-week-low of $18.00. Moreover, at the end of the last trading period, the closing price was at $37.01.</li><li>With a current rating of Buy, BTIG initiated coverage on <strong><a href=\"https://laohu8.com/S/EVRI\">Everi Holdings Inc</a></strong> (NYSE: EVRI). The price target seems to have been set at $12.00 for Everi Holdings. Everi Holdings earned $0.63 in the second quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $14.88 and a 52-week-low of $1.55. At the end of the last trading period, Everi Holdings closed at $7.08.</li><li>With a current rating of Equal-Weight, Morgan Stanley initiated coverage on <strong><a href=\"https://laohu8.com/S/ILMN\">Illumina</a> Inc</strong> (NASDAQ: ILMN). The price target seems to have been set at $400.00 for Illumina. Illumina earned $0.62 in the second quarter, compared to $1.35 in the year-ago quarter. The current stock performance of Illumina shows a 52-week-high of $404.20 and a 52-</li><li>Deutsche Bank initiated coverage on <strong>Stitch Fix Inc</strong> (NASDAQ: SFIX) with a Buy rating. The price target for Stitch Fix is set to $34.00. Stitch Fix earned $0.33 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Stitch Fix shows a 52-week-high of $30.44 and a 52-week-low of $10.90. Moreover, at the end of the last trading period, the closing price was at $26.60.</li><li>With a current rating of Buy, DA Davidson initiated coverage on <strong>eGain Corp</strong> (NASDAQ: EGAN). The price target seems to have been set at $16.00 for eGain. In the fourth quarter, eGain showed an EPS of $0.08, compared to $0.02 from the year-ago quarter. The current stock performance of eGain shows a 52-week-high of $14.85 and a 52-week-low of $4.80. Moreover, at the end of the last trading period, the closing price was at $11.14.</li><li>With a current rating of Overweight, Piper Sandler initiated coverage on <strong><a href=\"https://laohu8.com/S/FIVN\">Five9 Inc</a></strong> (NASDAQ: FIVN). The price target seems to have been set at $133.00 for Five9. Five9 earned $0.21 in the second quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $131.98 and a 52-week-low of $50.73. At the end of the last trading period, Five9 closed at $111.84.</li><li>With a current rating of Overweight, Morgan Stanley initiated coverage on <strong>Guardant Health Inc</strong> (NASDAQ: GH). The price target seems to have been set at $110.00 for Guardant Health. In the second quarter, Guardant Health showed an EPS of $0.57, compared to $0.13 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $100.00 and a 52-week-low of $55.90. Moreover, at the end of the last trading period, the closing price was at $90.97.</li><li>With a current rating of Overweight, JP Morgan initiated coverage on <strong>Horizon Therapeutics <a href=\"https://laohu8.com/S/PLC\">PLC</a></strong> (NASDAQ: HZNP). The price target seems to have been set at $110.00 for Horizon Therapeutics. Horizon Therapeutics earned $0.40 in the second quarter, compared to $0.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.93 and a 52-week-low of $23.81. Horizon Therapeutics closed at $69.70 at the end of the last trading period.</li><li>With a current rating of Equal-Weight, Morgan Stanley initiated coverage on <strong>Invitae Corp</strong> (NYSE: NVTA). The price target seems to have been set at $38.00 for Invitae. In the second quarter, Invitae showed an EPS of $0.77, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.22 and a 52-week-low of $7.42. Invitae closed at $30.23 at the end of the last trading period.</li><li>With a current rating of Buy, Loop Capital initiated coverage on <strong>Qualys Inc</strong> (NASDAQ: QLYS). The price target seems to have been set at $140.00 for Qualys. For the second quarter, Qualys had an EPS of $0.74, compared to year-ago quarter EPS of $0.55. The current stock performance of Qualys shows a 52-week-high of $125.22 and a 52-week-low of $63.37. Moreover, at the end of the last trading period, the closing price was at $98.67.</li><li>With a current rating of Hold, Loop Capital initiated coverage on <strong>SailPoint Technologies Holdings Inc</strong> (NYSE: SAIL). The price target seems to have been set at $40.00 for SailPoint Technologies. SailPoint Technologies earned $0.15 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $41.29 and a 52-week-low of $11.61. At the end of the last trading period, SailPoint Technologies closed at $37.41.</li><li>Evercore ISI Group initiated coverage on <strong>FedEx Corp</strong> (NYSE: FDX) with an Outperform rating. The price target for FedEx is set to $300.00. FedEx earned $2.53 in the fourth quarter, compared to $5.01 in the year-ago quarter. The current stock performance of FedEx shows a 52-week-high of $231.58 and a 52-week-low of $88.69. Moreover, at the end of the last trading period, the closing price was at $221.09.</li></ul><p type=\"text\"><strong>See more from Benzinga</strong></p><ul><li>Analyzing BP's Unusual Options Activity</li><li>Unusual Options Activity Insight: Intel</li><li>Unusual Options Activity Insight: Virgin Galactic Hldgs</li></ul><p type=\"text\"><i>© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p><div></div></div></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Benzinga's Top Upgrades, Downgrades For September 9, 2020</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBenzinga's Top Upgrades, Downgrades For September 9, 2020\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-09-09 21:44 GMT+8 <a href=https://finance.yahoo.com/news/benzingas-top-upgrades-downgrades-september-134444774.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>UpgradesFor Duke Energy Corp (NYSE: DUK), B of A Securities upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Duke Energy showed an EPS of $1.08, compared to $...</p>\n\n<a href=\"https://finance.yahoo.com/news/benzingas-top-upgrades-downgrades-september-134444774.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VCYT":"Veracyte Inc","SFIX":"Stitch Fix Inc.","PACB":"Pacific Biosciences of Californi","NSTG":"NanoString Technologies Inc.","ILMN":"Illumina","FIVN":"Five9 Inc","SPR":"Spirit AeroSystems Holdings Inc","EVRI":"Everi Holdings Inc"},"source_url":"https://finance.yahoo.com/news/benzingas-top-upgrades-downgrades-september-134444774.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2066247378","content_text":"UpgradesFor Duke Energy Corp (NYSE: DUK), B of A Securities upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Duke Energy showed an EPS of $1.08, compared to $1.12 from the year-ago quarter. The stock has a 52-week-high of $103.79 and a 52-week-low of $62.13. At the end of the last trading period, Duke Energy closed at $80.67.BMO Capital upgraded the previous rating for Sherwin-Williams Co (NYSE: SHW) from Market Perform to Outperform. In the second quarter, Sherwin-Williams showed an EPS of $7.10, compared to $6.57 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of $699.81 and a 52-week-low of $325.43. Moreover, at the end of the last trading period, the closing price was at $669.41.According to Wolfe Research, the prior rating for SmileDirectClub Inc (NASDAQ: SDC) was changed from Underperform to Peer Perform. Interestingly, in the second quarter, SmileDirectClub's EPS was $0.13. The current stock performance of SmileDirectClub shows a 52-week-high of $21.10 and a 52-week-low of $3.64. Moreover, at the end of the last trading period, the closing price was at $10.57.For Thor Industries Inc (NYSE: THO), BMO Capital upgraded the previous rating of Market Perform to the current rating Outperform. For the third quarter, Thor Industries had an EPS of $0.43, compared to year-ago quarter EPS of $1.65. The current stock performance of Thor Industries shows a 52-week-high of $121.33 and a 52-week-low of $32.30. Moreover, at the end of the last trading period, the closing price was at $92.41.For Aramark (NYSE: ARMK), Goldman Sachs upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, Aramark showed an EPS of $0.69, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $47.22 and a 52-week-low of $9.65. At the end of the last trading period, Aramark closed at $27.94.For Invitation Homes Inc (NYSE: INVH), Goldman Sachs upgraded the previous rating of Sell to the current rating Buy. Invitation Homes earned $0.32 in the second quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Invitation Homes shows a 52-week-high of $32.70 and a 52-week-low of $15.64. Moreover, at the end of the last trading period, the closing price was at $28.19.Deutsche Bank upgraded the previous rating for Vivint Smart Home Inc (NYSE: VVNT) from Hold to Buy. Vivint Smart Home earned $0.49 in the second quarter. The stock has a 52-week-high of $32.00 and a 52-week-low of $8.51. At the end of the last trading period, Vivint Smart Home closed at $15.58.MKM Partners upgraded the previous rating for Continental Resources Inc (NYSE: CLR) from Neutral to Buy. Continental Resources earned $0.71 in the second quarter, compared to $0.59 in the year-ago quarter. The current stock performance of Continental Resources shows a 52-week-high of $40.25 and a 52-week-low of $6.90. Moreover, at the end of the last trading period, the closing price was at $14.13.DowngradesAccording to Cowen & Co., the prior rating for Gogo Inc (NASDAQ: GOGO) was changed from Outperform to Market Perform. For the second quarter, Gogo had an EPS of $1.04, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $10.68 and a 52-week-low of $1.33. Gogo closed at $9.06 at the end of the last trading period.For Apartment Investment & Management Co (NYSE: AIV), Goldman Sachs downgraded the previous rating of Buy to the current rating Neutral. For the second quarter, Apartment Inv & Mgmt had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The current stock performance of Apartment Inv & Mgmt shows a 52-week-high of $55.68 and a 52-week-low of $24.53. Moreover, at the end of the last trading period, the closing price was at $36.79.For Essex Property Trust Inc (NYSE: ESS), Piper Sandler downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Essex Property Trust had an EPS of $3.16, compared to year-ago quarter EPS of $3.33. At the moment, the stock has a 52-week-high of $334.17 and a 52-week-low of $175.81. Essex Property Trust closed at $221.74 at the end of the last trading period.InitiationsMorgan Stanley initiated coverage on Veracyte Inc (NASDAQ: VCYT) with an Underweight rating. The price target for Veracyte is set to $35.00. Veracyte earned $0.22 in the second quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Veracyte shows a 52-week-high of $36.42 and a 52-week-low of $13.90. Moreover, at the end of the last trading period, the closing price was at $30.70.Morgan Stanley initiated coverage on Spirit AeroSystems Holdings Inc (NYSE: SPR) with an Underweight rating. The price target for Spirit AeroSystems Hldgs is set to $18.00. Spirit AeroSystems Hldgs earned $2.28 in the second quarter, compared to $1.71 in the year-ago quarter. The stock has a 52-week-high of $92.81 and a 52-week-low of $13.69. At the end of the last trading period, Spirit AeroSystems Hldgs closed at $20.23.Morgan Stanley initiated coverage on Pacific Biosciences of California Inc (NASDAQ: PACB) with a Equal-Weight rating. The price target for Pacific Biosciences is set to $7.00. In the second quarter, Pacific Biosciences showed an EPS of $0.15, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.25 and a 52-week-low of $2.20. Pacific Biosciences closed at $6.51 at the end of the last trading period.With a current rating of Equal-Weight, Morgan Stanley initiated coverage on NanoString Technologies Inc (NASDAQ: NSTG). The price target seems to have been set at $43.00 for NanoString Technologies. NanoString Technologies earned $0.72 in the second quarter, compared to $0.57 in the year-ago quarter. The current stock performance of NanoString Technologies shows a 52-week-high of $42.32 and a 52-week-low of $13.85. Moreover, at the end of the last trading period, the closing price was at $37.95.With a current rating of Outperform, Evercore ISI Group initiated coverage on DraftKings Inc (NASDAQ: DKNG). The price target seems to have been set at $60.00 for DraftKings. In the second quarter, DraftKings showed an EPS of $0.55, compared to $0.15 from the year-ago quarter. The current stock performance of DraftKings shows a 52-week-high of $44.79 and a 52-week-low of $18.00. Moreover, at the end of the last trading period, the closing price was at $37.01.With a current rating of Buy, BTIG initiated coverage on Everi Holdings Inc (NYSE: EVRI). The price target seems to have been set at $12.00 for Everi Holdings. Everi Holdings earned $0.63 in the second quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $14.88 and a 52-week-low of $1.55. At the end of the last trading period, Everi Holdings closed at $7.08.With a current rating of Equal-Weight, Morgan Stanley initiated coverage on Illumina Inc (NASDAQ: ILMN). The price target seems to have been set at $400.00 for Illumina. Illumina earned $0.62 in the second quarter, compared to $1.35 in the year-ago quarter. The current stock performance of Illumina shows a 52-week-high of $404.20 and a 52-Deutsche Bank initiated coverage on Stitch Fix Inc (NASDAQ: SFIX) with a Buy rating. The price target for Stitch Fix is set to $34.00. Stitch Fix earned $0.33 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Stitch Fix shows a 52-week-high of $30.44 and a 52-week-low of $10.90. Moreover, at the end of the last trading period, the closing price was at $26.60.With a current rating of Buy, DA Davidson initiated coverage on eGain Corp (NASDAQ: EGAN). The price target seems to have been set at $16.00 for eGain. In the fourth quarter, eGain showed an EPS of $0.08, compared to $0.02 from the year-ago quarter. The current stock performance of eGain shows a 52-week-high of $14.85 and a 52-week-low of $4.80. Moreover, at the end of the last trading period, the closing price was at $11.14.With a current rating of Overweight, Piper Sandler initiated coverage on Five9 Inc (NASDAQ: FIVN). The price target seems to have been set at $133.00 for Five9. Five9 earned $0.21 in the second quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $131.98 and a 52-week-low of $50.73. At the end of the last trading period, Five9 closed at $111.84.With a current rating of Overweight, Morgan Stanley initiated coverage on Guardant Health Inc (NASDAQ: GH). The price target seems to have been set at $110.00 for Guardant Health. In the second quarter, Guardant Health showed an EPS of $0.57, compared to $0.13 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $100.00 and a 52-week-low of $55.90. Moreover, at the end of the last trading period, the closing price was at $90.97.With a current rating of Overweight, JP Morgan initiated coverage on Horizon Therapeutics PLC (NASDAQ: HZNP). The price target seems to have been set at $110.00 for Horizon Therapeutics. Horizon Therapeutics earned $0.40 in the second quarter, compared to $0.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.93 and a 52-week-low of $23.81. Horizon Therapeutics closed at $69.70 at the end of the last trading period.With a current rating of Equal-Weight, Morgan Stanley initiated coverage on Invitae Corp (NYSE: NVTA). The price target seems to have been set at $38.00 for Invitae. In the second quarter, Invitae showed an EPS of $0.77, compared to $0.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.22 and a 52-week-low of $7.42. Invitae closed at $30.23 at the end of the last trading period.With a current rating of Buy, Loop Capital initiated coverage on Qualys Inc (NASDAQ: QLYS). The price target seems to have been set at $140.00 for Qualys. For the second quarter, Qualys had an EPS of $0.74, compared to year-ago quarter EPS of $0.55. The current stock performance of Qualys shows a 52-week-high of $125.22 and a 52-week-low of $63.37. Moreover, at the end of the last trading period, the closing price was at $98.67.With a current rating of Hold, Loop Capital initiated coverage on SailPoint Technologies Holdings Inc (NYSE: SAIL). The price target seems to have been set at $40.00 for SailPoint Technologies. SailPoint Technologies earned $0.15 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $41.29 and a 52-week-low of $11.61. At the end of the last trading period, SailPoint Technologies closed at $37.41.Evercore ISI Group initiated coverage on FedEx Corp (NYSE: FDX) with an Outperform rating. The price target for FedEx is set to $300.00. FedEx earned $2.53 in the fourth quarter, compared to $5.01 in the year-ago quarter. The current stock performance of FedEx shows a 52-week-high of $231.58 and a 52-week-low of $88.69. Moreover, at the end of the last trading period, the closing price was at $221.09.See more from BenzingaAnalyzing BP's Unusual Options ActivityUnusual Options Activity Insight: IntelUnusual Options Activity Insight: Virgin Galactic Hldgs© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":978806305,"gmtCreate":1599170643007,"gmtModify":1704221856863,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"快","listText":"快","text":"快","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/978806305","repostId":"2064325578","repostType":4,"repost":{"id":"2064325578","pubTimestamp":1599112868,"share":"https://www.laohu8.com/m/news/2064325578?lang=&edition=full","pubTime":"2020-09-03 14:01","market":"us","language":"zh","title":"《新股消息》报道指蚂蚁集团将於月底寻求上市批准 下月挂牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2064325578","media":"AAFN","summary":"《路透》旗下IFR引述知情人士指,阿里巴巴 旗下蚂蚁集团将於本月底寻求联交所批准上市,并拟於下月上市,A/H集资规模逾300亿美元。(vi/da)~阿思达克财经新闻网址: www.aastocks.","content":"<html><body><p>《路透》旗下IFR引述知情人士指,<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a> 旗下蚂蚁集团将於本月底寻求联交所批准上市,并拟於下月上市,A/H集资规模逾300亿美元。(vi/da)~阿思达克财经新闻网址: www.aastocks.com\t\t\t\t\t\t\t\t\t </p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》报道指蚂蚁集团将於月底寻求上市批准 下月挂牌</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》报道指蚂蚁集团将於月底寻求上市批准 下月挂牌\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-09-03 14:01 北京时间 <a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1041269&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>《路透》旗下IFR引述知情人士指,阿里巴巴 旗下蚂蚁集团将於本月底寻求联交所批准上市,并拟於下月上市,A/H集资规模逾300亿美元。(vi/da)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1041269&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/652439e9a583362a48785b3b6c9d61c0","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","09988":"阿里巴巴-W","00388":"香港交易所"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1041269&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2064325578","content_text":"《路透》旗下IFR引述知情人士指,阿里巴巴 旗下蚂蚁集团将於本月底寻求联交所批准上市,并拟於下月上市,A/H集资规模逾300亿美元。(vi/da)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":2158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947771382,"gmtCreate":1597442341246,"gmtModify":1704215893648,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","listText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","text":"$TFF Pharmaceuticals(TFFP)$Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/947771382","isVote":1,"tweetType":1,"viewCount":3574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947552546,"gmtCreate":1597367666985,"gmtModify":1704215604434,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","listText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","text":"$英特尔(INTC)$感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/947552546","isVote":1,"tweetType":1,"viewCount":5327,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":947552546,"gmtCreate":1597367666985,"gmtModify":1704215604434,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","listText":"<a href=\"https://laohu8.com/S/INTC\">$英特尔(INTC)$</a>感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","text":"$英特尔(INTC)$感觉英特尔和台积电还有一拼吧,最新的消息英特尔架构日,英特尔公布了全新的10纳米SuperFET技术和“分解”设计封装技术!以IDM模式运营的英特尔不一定需要和以代工模式运营的台积电去比拼工艺,因为台积电不是英特尔的真实对手,只要透过六大技术支柱的巧妙组合,去迎战真实对手即可。打败对手就赢得天下!在英特尔和台积电分别推出3D封装技术Foveros和SOIC后,以“打酱油”著称的三星电子日前也紧急披露3D封装X-Cube,全球3D封装大战一触即发。感觉英特尔后面还有机会","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/947552546","isVote":1,"tweetType":1,"viewCount":5327,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":947771382,"gmtCreate":1597442341246,"gmtModify":1704215893648,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","listText":"<a href=\"https://laohu8.com/S/TFFP\">$TFF Pharmaceuticals(TFFP)$</a>Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","text":"$TFF Pharmaceuticals(TFFP)$Tffp新药技术。Niclosamide是一种口服驱虫药,于1982年被美国FDA首次批准用于人类,并被列入世界卫生组织的基本药物清单。它已被用于安全地治疗数百万患者。最近,通过重新定位药物用途的筛选,Niclosamide已被确认为一种多功能药物,有潜力重新用于治疗多种病毒感染,例如严重急性呼吸综合征冠状病毒(SARS-CoV),中东呼吸综合征冠状病毒(MERS- CoV),寨卡病毒(ZIKV)等产品,因为其价格便宜且在临床上作为一种FDA批准的药物具有较低的体内毒性。氯硝柳胺已显示出对SARS-CoV-2和完全消除了1.56μM浓度下的病毒抗原合成。但是,烟酰胺具有有限的水溶性,低吸收和口服生物利用度,对其作为潜在抗病毒疗法的发展提出了挑战。TFF Pharmaceuticals的TFF技术已证明可以改善口服形式的氯硝柳胺的溶解度以及干粉形式的药物以直接递送至肺部。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/947771382","isVote":1,"tweetType":1,"viewCount":3574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":978806305,"gmtCreate":1599170643007,"gmtModify":1704221856863,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"快","listText":"快","text":"快","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/978806305","repostId":"2064325578","repostType":4,"isVote":1,"tweetType":1,"viewCount":2158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":976606803,"gmtCreate":1599674612502,"gmtModify":1703819349712,"author":{"id":"77318222255148","authorId":"77318222255148","name":"虎皮猫","avatar":"https://static.tigerbbs.com/b9c3b91bc0b93aeb280241bc2e9f54a0","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"77318222255148","authorIdStr":"77318222255148"},"themes":[],"htmlText":"听听就好了","listText":"听听就好了","text":"听听就好了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/976606803","repostId":"2066247378","repostType":2,"isVote":1,"tweetType":1,"viewCount":1955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}